Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pneumococcal vaccination practices among private physicians

P A Patriarca, W F Schlech, A R Hinman

    Public Health Reports (Washington, D.C. : 1974)
    |September 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Immunization against pneumococcal disease in HIV-infected patients: conjugate versus polysaccharide vaccine before or after reconstitution of the immune system (CTN-147).

    International journal of STD & AIDS·2013
    Same author

    What do we do about Listeria monocytogenes?

    The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses·2012
    Same author

    Unanswered questions in central nervous system infection.

    The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses·2012
    Same author

    The epidemiology of immune thrombocytopenia.

    The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses·2012
    Same author

    A randomized double-blind placebo controlled trial of oral acyclovir in renal allograft recipients.

    The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses·2012
    Same author

    Hepatotoxicity from first line antiretroviral therapy: an experience from a resource limited setting.

    African health sciences·2011
    Same journal

    Experiential and Structural Determinants of Communicable Disease Reporting Among Health Care Providers in Alameda County, California.

    Public health reports (Washington, D.C. : 1974)·2026
    Same journal

    A Case-Case Study of Sporadic and Outbreak-Associated Listeriosis Exposures: <i>Listeria</i> Initiative Food History Data, 2016-2022.

    Public health reports (Washington, D.C. : 1974)·2026
    Same journal

    Developing a Prioritization Method for Imported Infectious Diseases Using National Notifiable Surveillance Data: The Tokyo 2020 Olympic and Paralympic Games Experience.

    Public health reports (Washington, D.C. : 1974)·2026
    Same journal

    Reduction in Hepatitis C Virus RNA Positivity Among Clients in an Inpatient Substance Use Treatment Program in New York City.

    Public health reports (Washington, D.C. : 1974)·2026
    Same journal

    Managing Institutional Change Through Participatory Planning: Creating the College of Integrated Health Sciences at the University at Albany, State University of New York.

    Public health reports (Washington, D.C. : 1974)·2026
    Same journal

    An Urgent Need for Evidence-Based Guidance on Mercury Exposure Screening to Inform Public Health Policy, Practice, and Prevention.

    Public health reports (Washington, D.C. : 1974)·2026
    See all related articles

    Less than 10% of high-risk patients received the 14-valent pneumococcal polysaccharide vaccine. Physicians primarily vaccinated patients with cardiorespiratory diseases, despite agreeing on broader indications for pneumococcal disease prevention.

    Area of Science:

    • Infectious Diseases
    • Vaccinology
    • Public Health

    Background:

    • Invasive pneumococcal diseases pose a significant risk to specific patient populations.
    • The 14-valent pneumococcal polysaccharide vaccine is indicated for high-risk individuals.
    • Current vaccination rates among at-risk patients are estimated to be below 10%.

    Purpose of the Study:

    • To assess the vaccination practices of primary care physicians regarding the 14-valent pneumococcal polysaccharide vaccine.
    • To identify specific high-risk groups most likely to receive the vaccine.
    • To investigate the discrepancy between physician attitudes and actual vaccination practices.

    Main Methods:

    • Nationwide survey of 893 private, primary-care physicians.
    • Data collection on physician attitudes towards vaccine indications and reported vaccination practices.

    Related Experiment Videos

  • Analysis of vaccination patterns across different high-risk patient groups.

    • Main Results:

    • General physician agreement on the vaccine's indication for high-risk groups.
    • Only patients with cardiorespiratory diseases were consistently immunized by over half of respondents.
    • No specific factor was identified to explain the gap between stated attitudes and vaccination practices.

    Conclusions:

    • A significant gap exists between physician knowledge of pneumococcal vaccine indications and actual clinical practice.
    • Vaccination practices for high-risk patients are inconsistent, with cardiorespiratory patients being a notable exception.
    • Further research is needed to understand and address the barriers to optimal pneumococcal vaccination coverage.